Post job

Ivenix main competitors are Endologix, Copley Controls, and Bioventus.

Competitor Summary. See how Ivenix compares to its main competitors:

  • Bioventus has the most employees (1,062).
  • Employees at Endologix earn more than most of the competitors, with an average yearly salary of $71,608.
  • The oldest company is Copley Controls, founded in 1978.
Work at Ivenix?
Share your experience

Ivenix vs competitors

CompanyFounding dateZippia scoreHeadquarters# of LocationsRevenueEmployees
2007
4.1
North Andover, MA3$9.9M49
1992
4.7
Irvine, CA2$95.3M488
2005
4.2
Madison Heights, MI5$134.9M282
1988
4.5
-4$303.9M1,050
2011
4.2
Durham, NC2$321.2M1,062
2005
4.0
Hicksville, OH1$138.0M203
1997
4.4
Mountain View, CA1$79.9M152
1978
4.0
Canton, MA1$32.2M200

Rate how well Ivenix differentiates itself from its competitors.

Zippia waving zebra

Ivenix salaries vs competitors

Among Ivenix competitors, employees at Endologix earn the most with an average yearly salary of $71,608.

Compare Ivenix salaries vs competitors

CompanyAverage salaryHourly salarySalary score
Ivenix
$45,715$21.98-
Endologix
$71,608$34.43-
InfuSystem
$51,968$24.98-
AngioDynamics
$50,008$24.04-
Bioventus
$54,381$26.14-
Avalign Technologies
$42,268$20.32-

Compare Ivenix job title salaries vs competitors

CompanyHighest salaryHourly salary
Ivenix
$32,131$15.45
AngioDynamics
$35,228$16.94
Bioventus
$32,537$15.64
InfuSystem
$32,453$15.60
Endologix
$32,386$15.57
NeuroPace
$32,273$15.52
Avalign Technologies
$30,896$14.85
Copley Controls
$30,817$14.82

Do you work at Ivenix?

Does Ivenix effectively differentiate itself from competitors?

Ivenix jobs

Ivenix demographics vs competitors

Compare gender at Ivenix vs competitors

Job titleMaleFemale
InfuSystem41%59%
AngioDynamics47%53%
Endologix55%45%
Avalign Technologies57%43%
Ivenix--
Male
Female
100%
75%
50%
25%
0%
0%
25%
50%
75%
100%

Compare race at Ivenix vs competitors

CompanyWhiteHispanic or LatinoBlack or African AmericanAsianUnknownDiversity score
61%11%16%8%4%
9.7
37%21%5%32%5%
9.3
68%11%13%6%2%
7.7
74%10%8%6%2%
6.2

Ivenix and similar companies CEOs

CEOBio
James Christopher Clemmer
AngioDynamics

President and Chief Executive Officer Jim Clemmer joined AngioDynamics in April 2016, bringing more than 25 years of leadership within the healthcare industry and a proven track record of success. Prior to AngioDynamics, Clemmer served as president of the $1.8 billion medical supplies segment at Covidien plc., where he directed strategic and day-to-day operations for global business divisions that collectively manufactured 23 different product categories. In addition, he managed global manufacturing, research and development, operational excellence, business development and all other functions associated with the medical supplies business. Prior to his role at Covidien, Clemmer served as group president at Kendall Healthcare, where he managed the US business across five divisions and built the strategic plan for the Medical Supplies segment before it was spun off from Tyco. Clemmer began his career at Sage Products, Inc. Clemmer currently serves on the Board of Directors for AngioDynamics and Lantheus Medical Imaging. Clemmer is a graduate of the Massachusetts College of Liberal Arts.

John Onopchenko
Endologix

John Onopchenko is a Board Member at Synecor, Board Member at Endologix Inc, and Chief Executive Officer at Endologix Inc. He has worked as Chief Operating Officer at VOLCANO CO., LTD.; Chief Operating Officer at Endologix Inc; and Exec VP:Strategy at VOLCANO CO., LTD.. John works or has worked as VP:Venture Investments at Johnson & Johnson Innovation - Jjdc Inc, Managing Director/Gen Partner at Synergy Life Sciences Partners, and MEMBER at FINRA. He studied at University of Chicago Booth School of Business and Ursinus College.

Richard Diiorio
InfuSystem

Kenneth Michael Reali
Bioventus

Healthcare business executive with broad experience in product development, global marketing, commercialization and sales of medical devices. Strong background in market analysis, reimbursement strategy, regulatory and clinical affairs, new product development, sales force optimization and domestic and international product commercialization. Specialty experience working with medical societies, patient advocacy groups, governmental agencies, public and private insurance companies, investor relations, capital funding, business development and strategy development including strategic planning and acquisitions.

Matthew Lorber
Copley Controls

Matthew Lorber is the current President, Treasurer, and Chief Executive Officer of Copley Controls Corp.

Michael Favet
NeuroPace

Mike brings over 20 years of medical device industry experience to Sonitus. Prior to joining Sonitus in June 2012, Mike accumulated broad cross-functional experience in medical device companies of various sizes with products in diverse therapeutic areas. Mike served as Senior Vice President of Science, Technology & Operations for Ventus Medical where he led the R&D, manufacturing, clinical, quality, regulatory and reimbursement functions for this venture-backed company with a novel device for the treatment of obstructive sleep apnea. While at Ventus, Mike led the organization through several product launches, the completion and publication of 7 clinical studies, and the scaling up of manufacturing to support commercial launch. Mike also held vice president level positions in R&D and operations in the Cardiac Surgery business units of Guidant, Boston Scientific and Maquet. Additionally, Mike held various positions in the Cardiac Rhythm Management business of Guidant including leadership roles in R&D and project management as well as roles in field clinical, design and manufacturing engineering. Mike received a Bachelor of Science degree in Mechanical Engineering from the University of Illinois and an MBA from the University of Minnesota.

Jeffery A. McCaulley
Avalign Technologies

Mr. McCaulley brings over 30 years of experience in the medical device industry, having most recently served as the President of DJO Surgical, where he helped to build one of the fastest growing companies in shoulder, hip, and knee joint reconstruction with a strong focus on innovation, commercial programs, customer engagement, and operational excellence. Prior to DJO Surgical, Mr. McCaulley served as the President and CEO of Smiths Medical, President of Zimmer Holdings’ Global Reconstructive Division, and President and CEO of WK Health. Mr. McCaulley has also held senior executive positions with Medtronic and General Electric Healthcare, including President and CEO of GE Clinical Services. Mr. McCaulley earned a Bachelor of Science in Aerospace Engineering from the University of Cincinnati and a Master of Business Administration from the Owen Graduate School of Management at Vanderbilt University.

Ivenix competitors FAQs

Search for jobs